apl. Prof. Dr. Stefan Krause

Medizinische Fakultät Department of Medicine 5 – Haematology and Oncology

Nilotinib Vs Nilotinib Plus Pegylated Interferon a (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response (2019) Hochhaus A, Burchert A, Saussele S, Baerlocher GM, Brummendorf TH, Rosee PL, Heim D, et al. Conference contribution Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group (2019) Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A, Greil R, Sasse S, et al. Journal article Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis (2019) Boch T, Spiess B, Heinz W, Cornely OA, Schwerdtfeger R, Hahn J, Krause S, et al. Journal article Identifying the need for specialized palliative care in adult cancer patients - Development and validation of a screening procedure based on proxy assessment by physicians and filter questions (2019) Ostgathe C, Wendt KN, Heckel M, Kurkowski S, Klein C, Krause S, Fuchs F, et al. Journal article Efficient Elimination of Cells from Patients with Different AML Subtypes by Dual-Targeting Triplebody 33-16-123 (2019) Braciak T, Fenn N, Wildenhain S, Schiller C, Roskopf C, Schubert I, Jacob U, et al. Conference contribution Pet positivity after 2 cycles of abvd is a risk factor in patients with early-stage favorable Hodgkin lymphoma treated in the phase 3 GHSG HD16 study (2019) Fuchs M, Goergen H, Kobe C, Kuhnert G, Hitz F, Greil R, Sasse S, et al. Conference contribution Impact of comorbidities on outcome with second and further line TKI treatment in patients with chronic myeloid leukemia (2019) Yildirim-Zuemruet G, Kohlbrenner K, Hehlmann R, Fabarius A, Baerlocher GM, Krause S, Burchert A, et al. Conference contribution Blood counts in adults and elderly individuals (2019) Zierk J, Krebs A, Rauh M, Metzler M, Parsch H, Strasser E, Krause S Conference contribution Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia (2018) Middeke JM, Rollig C, Kramer M, Kramer A, Bochtler T, Scholl S, Hochhaus A, et al. Conference contribution EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia (2018) Stasik S, Middeke JM, Kraemer M, Rollig C, Kramer A, Scholl S, Hochhaus A, et al. Conference contribution